CaliPharms, Inc. (KGET)
CaliPharms, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Temecula, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $474,349. On trailing twelve-month figures it carries a trailing P/E of -0.40, a net margin of -11861.4%. Its beta of 5.30 implies it has historically moved more than the broad market.
CaliPharms, Inc. is an entity actively engaged in the medicinal cannabis industry across the United States. The company's primary focus lies within the THC and CBD-infused beverage sector. It rebranded to CaliPharms, Inc. in January 2017, having previously operated under the name Kleangas Energy Technologies, Inc. The corporate headquarters for CaliPharms, Inc. are located in Temecula, California.
CaliPharms, Inc. is most often compared with the following Healthcare names: